-
Product Insights
Cystitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Cystitis - Drugs In Development, 2023’, provides an overview of the Cystitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cystitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Hemorrhagic Cystitis (Haemorrhagic Cystitis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Hemorrhagic Cystitis (Haemorrhagic Cystitis) - Drugs In Development, 2023’, provides an overview of the Hemorrhagic Cystitis (Haemorrhagic Cystitis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hemorrhagic Cystitis (Haemorrhagic Cystitis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Dyspareunia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Dyspareunia Global Clinical Trials Review, H2, 2017" provides an overview of Dyspareunia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspareunia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...